Biotech

All Articles

Lilly- backed weight loss biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis usage medicine flunks phase 2b, steering Indivior to review $100M alternative

.Aelis Farma's chances of protecting a quick, favorable selection on a $100 million choice remittanc...

ProKidney standstills phase 3 trial not required for cell therapy approval

.ProKidney has quit one of a set of phase 3 trials for its cell therapy for renal illness after deci...

Vaxcyte rises on 'stunning' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what analysts referred to as "spectacular" stage 1/2 records for its own 31-valent...

Recursion's mind illness trial reveals little evidence of efficacy

.Recursion has discovered with a very early test of its own tech-enabled approach to medication disc...

Acepodia, Pfizer click with each other for chemistry-based tissue treatment

.Phone it a scenario of great chemical make up: Acepodia, a biotech based on Nobel Champion scientif...

Praxis epilepsy drug minimizes seizures in period 2 trial

.Praxis Accuracy Medicines has actually scored another midphase succeed in epilepsy this year, with ...

Three directors resign as Dyne articles blended records for DMD candidate

.After leaving a medical grip a number of years back, Dyne Therapeutics has revealed brand new perio...

Arrowhead fires off stage 3 information in uncommon metabolic condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its give before a potential face-off with Ionis, relea...

Pfizer, Valneva present lyme illness try helpful for second booster

.Pfizer as well as Valneva might possess regarding 2 additional years to stand by prior to they help...